Clinical Trial Update: Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome. [Phase 2]

View source ↗

Summary

Update on an open-label Phase 2 trial of triheptanoin (UX007) for Rett syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Rett Syndrome | Phase 2 | Status: UNKNOWN